tirzepatide injection needle Zepbound 5 mg/0.5 mL — Mountainside Medical By activating both of these hormones Tirzepatide Tops Semaglutide for Weight

Wegovy is brand-name semaglutide manufactured by Novo Nordisk

The oral version showed 12.2% weight loss at 13 weeks in Phase 2, and Phase 3 is expected to begin in Q4 2026

The largest of the trials lasted 12 months and included over 3000 participants

Full Answer: AOD-9604 completed six human clinical trials involving over 900 participants, and its safety profile was consistently favorable

The 24.2% average weight loss seen with Retatrutide approaches the results typically achieved with bariatric surgery, which produces 25-30% weight loss

In 2022, Eli Lilly introduced Mounjaro (tirzepatide), a dual GLP-1/glucose-dependent insulinotropic polypeptide (GIP) receptor agonist, as a direct competitor of Ozempic